These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 7325754)

  • 21. Role of binding in distribution of furosemide: where is nonrenal clearance?
    Branch RA
    Fed Proc; 1983 Apr; 42(6):1699-702. PubMed ID: 6832389
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clearance of furosemide by the gastrointestinal tract.
    Valentine JF; Brater DC; Krejs GJ
    J Pharmacol Exp Ther; 1986 Jan; 236(1):177-80. PubMed ID: 3941391
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics, plasma protein binding and bioavailability of moxifloxacin in Muscovy ducks after different routes of administration.
    Goudah A; Hasabelnaby S
    Res Vet Sci; 2010 Jun; 88(3):507-11. PubMed ID: 20004428
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The influence of indomethacin on the pharmacokinetics, diuretic response and hemodynamics of furosemide in the dog.
    Data JL; Rane A; Gerkens J; Wilkinson GR; Nies AS; Branch RA
    J Pharmacol Exp Ther; 1978 Aug; 206(2):431-8. PubMed ID: 682123
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical pharmacokinetics of furosemide in children with nephrotic syndrome.
    González-Martín G; Bravo I; Ibarra N; Arancibia A
    Int J Clin Pharmacol Ther Toxicol; 1983 Dec; 21(12):598-601. PubMed ID: 6668097
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Application of an enzyme-multiplied immunoassay technique for determination of caffeine elimination kinetics as a test of liver function in clinically normal dogs.
    Golden DL; Spano JS; Wilson RC; DeGraves FJ; Whatley EM
    Am J Vet Res; 1994 Jun; 55(6):790-4. PubMed ID: 7944016
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Determinants of the overall response to furosemide: pharmacokinetics and pharmacodynamics.
    Brater DC
    Fed Proc; 1983 Apr; 42(6):1711-3. PubMed ID: 6832391
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Furosemide kinetics in renal failure.
    Tilstone WJ; Fine A
    Clin Pharmacol Ther; 1978 Jun; 23(6):644-50. PubMed ID: 648078
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analytical determination and pharmacokinetics of robenacoxib in the dog.
    Jung M; Lees P; Seewald W; King JN
    J Vet Pharmacol Ther; 2009 Feb; 32(1):41-8. PubMed ID: 19161454
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics and tissue residue profiles of erythromycin in broiler chickens after different routes of administration.
    Goudah A; Abo El Sooud K; Abd El-Aty AM
    Dtsch Tierarztl Wochenschr; 2004 Apr; 111(4):162-5. PubMed ID: 15171602
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Disposition kinetics and tissue residues of danofloxacin in Muscovy ducks.
    Goudah A; Mouneir SM
    Br Poult Sci; 2009 Sep; 50(5):613-9. PubMed ID: 19904641
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Absorption and disposition of furosemide in healthy volunteers, measured with a metabolite-specific assay.
    Smith DE; Lin ET; Benet LZ
    Drug Metab Dispos; 1980; 8(5):337-42. PubMed ID: 6107232
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics and tissue residues of josamycin in fowls.
    el-Sayed MG; Abd el-Aziz MI; Abd el-Azem AM
    Dtsch Tierarztl Wochenschr; 1992 Mar; 99(3):113-6. PubMed ID: 1576948
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics of diazepam in the dog.
    Löscher W; Frey HH
    Arch Int Pharmacodyn Ther; 1981 Dec; 254(2):180-95. PubMed ID: 7337498
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Absorption and tissue distribution of a novel carboxymethyldextran after oral administration.
    Charef S; Papy-Garcia D; Courty J
    Biomed Pharmacother; 2010 Nov; 64(9):627-32. PubMed ID: 20888180
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics of florfenicol and its metabolite, florfenicol amine, in dogs.
    Park BK; Lim JH; Kim MS; Hwang YH; Yun HI
    Res Vet Sci; 2008 Feb; 84(1):85-9. PubMed ID: 17570454
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The pharmacokinetics of maropitant, a novel neurokinin type-1 receptor antagonist, in dogs.
    Benchaoui HA; Cox SR; Schneider RP; Boucher JF; Clemence RG
    J Vet Pharmacol Ther; 2007 Aug; 30(4):336-44. PubMed ID: 17610407
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics of furosemide in man after intravenous and oral administration. Application of moment analysis.
    Hammarlund MM; Paalzow LK; Odlind B
    Eur J Clin Pharmacol; 1984; 26(2):197-207. PubMed ID: 6723758
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diuretic effect and disposition of furosemide in cystic fibrosis.
    Prandota J; Smith IJ; Hilman BC; Wilson JT
    Eur J Clin Pharmacol; 1991; 40(4):333-41. PubMed ID: 2050167
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dose-dependent pharmacokinetics of furosemide in the rat.
    Hammarlund MM; Paalzow LK
    Biopharm Drug Dispos; 1982; 3(4):345-59. PubMed ID: 7159689
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.